CDKN2A (9p21) / 9q21 (tissue) probe hybridized to tissue (2R2G).
CDKN2A (9p21) / 9q21 (tissue) probe hybridized to tissue (2R2G).
RUO - CDKN2A / 9q21 (tissue)
Homozygous and hemizygous deletions of 9p21 are the earliest and most common genetic alteration in bladder cancer. The CDKN2A (INK4A) gene has been identified as tumor suppressor gene in this region which is commonly deleted in bladder cancer. The loss of DNA sequences on chromosomal bands 9p21-22 has been documented also in a variety of malignancies including leukemias, gliomas, lung cancers, and melanomas. The CDKN2A (9p21) FISH probe is optimized to detect copy numbers of the CDKN2A gene region at region 9p21. The 9q21 region probe is included to facilitate chromosome identification.
References: Stadler et al, 1994, Cancer Res, 54:2260-2063. Williams et al, 1995, Hum Mol Genet; 4: 1569-1577.
제품
제품
KI-10710
CDKN2A (9p21) / 9q21 (tissue)
Product is out of stock
Due to manufacturing & supply chain issues, this product is currently unavailable. You may place your order and it will be fulfilled when the product is back in stock. For more help, please reach out to customer service at +1 844 534 2262 or nonurgentcs@leicabiosystems.com
Product is limited in stock
Product availability is limited, but products are in continuous production. Your order will be processed as normal and may take additional days to ship.